Welcome to our dedicated page for YSX Tech. Co. news (Ticker: YSXT), a resource for investors and traders seeking the latest updates and insights on YSX Tech. Co. stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect YSX Tech. Co.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of YSX Tech. Co.'s position in the market.
YSX TECH (YSXT) has successfully completed its Initial Public Offering (IPO) on December 19, 2024, raising total gross proceeds of $5.75 million. The company offered 1,250,000 Class A ordinary shares at $4.00 per share, with an additional 187,500 shares sold through the full exercise of the underwriter's over-allotment option. Trading commenced on the Nasdaq Capital Market under the symbol 'YSXT' on December 18, 2024.
The company, operating through variable interest entities in China, provides comprehensive business solutions for insurance companies and brokerages. The IPO proceeds will fund business expansion, new market development, product R&D, talent recruitment, and working capital needs. Kingswood Capital Partners acted as the sole book-runner for this firm commitment offering.
YSX TECH (NASDAQ: YSXT) has announced the pricing of its Initial Public Offering of 1,250,000 Class A ordinary shares at $4.00 per share, raising approximately $5 million in gross proceeds. The company provides business solutions for insurance companies and brokerages in China through its variable interest entities. Trading is expected to commence on December 18, 2024, on the Nasdaq Capital Market. Underwriters have a 45-day option to purchase up to 187,500 additional shares. The offering, managed by Kingswood Capital Partners as sole book-runner, is expected to close on December 19, 2024. Proceeds will fund business expansion, market development, R&D, talent recruitment, and working capital.
FAQ
What is the current stock price of YSX Tech. Co. (YSXT)?
What is the market cap of YSX Tech. Co. (YSXT)?
